Clinical Trial Update: Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating inhaled milrinone and epoprostenol for prevention of difficult separation from cardiopulmonary bypass; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Right Heart Failure
• Right Ventricular Dysfunction

Drugs mentioned

• Epoprostenol (Flolan) (epoprostenol)
• Milrinone (Primacor) (milrinone)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Right Heart Failure, Right Ventricular Dysfunction | Phase 2 | Status: NOT_YET_RECRUITING